Related Articles
linc‑ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1‑mediated epithelial‑mesenchymal transition
Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma
Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro
NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
FK866 inhibits the epithelial‑mesenchymal transition of hepatocarcinoma MHCC97‑H cells